Literature DB >> 15040938

Dendritic cell-based vaccination against opportunistic fungi.

Silvia Bozza1, Claudia Montagnoli, Roberta Gaziano, Giordano Rossi, Gabriel Nkwanyuo, Silvia Bellocchio, Luigina Romani.   

Abstract

Efficient responses to the different forms of fungi require different mechanisms of immunity. Dendritic cells (DCs) are uniquely able to decode the fungus-associated information and translate it in qualitatively different T helper (Th) immune responses, in vitro and in vivo. DCs sense fungi in a morphotype-specific manner, through the engagement of distinct recognition receptors ultimately affecting cytokine production and costimulation. Adoptive transfer of different types of DCs activates protective and non-protective Th cells as well as regulatory T cells and affects the outcome of the infections. DCs transfected with fungal RNA also restore antifungal resistance in hematopoietic transplantation. Thus, the remarkable functional plasticity of DCs in response to fungi can be exploited for the deliberate targeting of cells and pathways of cell-mediated immunity in response to fungal vaccines.

Mesh:

Substances:

Year:  2004        PMID: 15040938     DOI: 10.1016/j.vaccine.2003.11.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

Authors:  James I Ito; Joseph M Lyons; Teresa B Hong; Daniel Tamae; Yi-Kuang Liu; Sharon P Wilczynski; Markus Kalkum
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

2.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 3.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 4.  [Therapeutic or prophylactic antifungal vaccination: problems and solutions].

Authors:  S Boneberger; H C Korting
Journal:  Hautarzt       Date:  2008-10       Impact factor: 0.751

Review 5.  Dendritic cells in antifungal immunity and vaccine design.

Authors:  René M Roy; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

6.  CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.

Authors:  Diana Diaz-Arevalo; Karine Bagramyan; Teresa B Hong; James I Ito; Markus Kalkum
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 7.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

8.  Induction of protective immunity against Eimeria tenella, Eimeria maxima, and Eimeria acervulina infections using dendritic cell-derived exosomes.

Authors:  Emilio del Cacho; Margarita Gallego; Sung Hyen Lee; Hyun Soon Lillehoj; Joaquin Quilez; Erik P Lillehoj; Caridad Sánchez-Acedo
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

9.  Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.

Authors:  Kristin J Carpenter; Cory M Hogaboam
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

10.  Molecular characterization and immune protection of an AN1-like zinc finger protein of Eimeria tenella.

Authors:  Huanzhi Zhao; Qiping Zhao; Shunhai Zhu; Bing Huang; Ling Lv; Guiling Liu; Zhihang Li; Lu Wang; Hui Dong; Hongyu Han
Journal:  Parasitol Res       Date:  2019-11-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.